Booth 2075
AbCheck’s unique drug discovery platform enables reliable discovery of next-generation protein therapeutics, offering modular solutions to overcome target-specific challenges for improved drug discovery campaign success rates.
Booth 2075
APIGENEX s.r.o. is a growing Contract Research Organization located in the centre of Europe (Prague, CZ). It split from the largest pharmaceutical R&D centre in former Czechoslovakia in 1999 and has continued in its long tradition of pharmaceutical research.
APIGENEX has been in and benefited from the continuous and close partnership with Novo Nordisk A/S Denmark in the research of treatments for diabetes/obesity for 25 years.
APIGENEX provides high quality services in pre-clinical development and early-stage discovery in three major fields – medicinal chemistry, peptide synthesis and in-vivo/ in-vitro experimental pharmacology – to both Czech and international pharmaceutical companies.
APIGENEX has recently expanded its activities to include a small-scale GMP / GLP production of highly potent API (peptides, glycopeptides).
APIGENEX has been involved in a number of research collaborations with academic institutions.
Open and interactive communication with clients is standard along with flexibility and strict confidentiality.
Booth 2075
IOCB Tech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.
The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.
An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.
Booth 2075
Santiago lab is a chemical CRO that specializes in providing services for custom synthesis and contract research. The whole company is located in Prague, Czech Republic. Santiago lab offers custom synthesis of previously reported molecules using described synthetic procedures as well as new, undescribed compounds through developing novel synthetic routes.